Does Fridays Semaglutide Work? Here's What Actually Decides Your Result

Affiliate disclosure: We may earn a commission if you start with Fridays or Ro through a link on this page. It costs you nothing extra. It did not change a single finding below — including the findings that could cost us the sale. The sources behind the major claims are listed at the end so you can open them yourself.

Does Fridays semaglutide work? Yes, semaglutide can cause meaningful weight loss. But Fridays has not published a clinical trial of the compounded semaglutide offered through its program, and that compounded medication is not FDA-approved.

The strong proof belongs to FDA-approved Wegovy — including the weekly injection and the approved daily tablet — not to a Fridays compounded vial. Fridays says this itself: compounded medications offered through its program have not been evaluated by FDA for safety, effectiveness, or quality.

That sounds like bad news. It isn't, exactly — and here's the part almost nobody tells you.

Your result is not decided by one headline number. It can change with the exact product and route you receive, the dose your clinician selects, how long you stay on treatment, whether side effects stop you, and whether you have a long break in care.

A real-world study followed 6,109 people who started injectable semaglutide. Average one-year weight loss was 7.7%. It was 10.9% among people who did not have a treatment gap longer than 90 days, and 13.7% among those who also reached what the study called a high maintenance dose. That study did not test Fridays, and it does not prove that staying on treatment caused every pound. It does show why dose, time, and long gaps matter.

The seven facts that answer the question

1. Semaglutide works. FDA-approved Wegovy injection produced about 14.9% average weight loss at 68 weeks in STEP 1. The current FDA-approved Wegovy tablet produced 13.6% at 64 weeks in the study listed in its label.
2. Fridays' compounded semaglutide is not the product those trials tested. We found no published clinical trial of a Fridays compounded semaglutide product as of August 28, 2026.
3. Fridays' “96.8% success rate” is not a weight-loss rate. Its own footnote says it measures recent fulfillment and delivery performance for paid orders.
4. Fridays' 9.75-pound and 15.28% figures are not semaglutide-only results. Its disclaimer says those internal outcomes span a range of prescribed medications.
5. In the Cleveland Clinic study, the semaglutide-only one-year averages were 7.7%, 10.9%, and 13.7%, depending on treatment continuity and dose group. Those are averages, not promises.
6. Fridays changed compounded-medication refills on August 27, 2026. One approved request now covers a 12-week prescription with three shipments sent about four weeks apart. Billing stays on its own cycle.
7. Fridays' live prices conflict. Its pages currently show $117, $150, $249, and $279 in different places. The current help center lists $249 month to month and lower effective rates for prepaid plans. The final checkout terms control what you agree to pay.

So the honest question is not just “does Fridays semaglutide work?” It is: am I comfortable choosing a compounded product without product-specific trial proof, and does this program make sense for my medical need, budget, and ability to stay engaged?

Best for you if:

• You understand this is compounded semaglutide, not an FDA-approved Wegovy product
• Your clinician can explain the patient-specific reason a compounded version is appropriate for you
• You are paying cash and can afford the full term you choose, including any large upfront payment
• You are willing to give treatment months, not “try it for 30 days”
• You will use the provider, dietitian, coaching, and support access included in the program
• You will check the pharmacy, exact ingredient, concentration, route, storage rules, and dose on your own label

Probably not for you if:

• You want the exact product the clinical trials studied
• You have insurance that might cover Wegovy or Zepbound — check that first
• You are expecting guaranteed results, or a refund if you do not lose weight
• You want to choose a specific compounding pharmacy before you enroll
• You are pregnant, trying to become pregnant, or breastfeeding and have not discussed the plan with your clinician
• You or a family member has had medullary thyroid cancer, or you have MEN 2 — those are contraindications on the approved Wegovy label, and your prescriber needs to know

The right GLP-1 path is not the same for everyone. It depends on your state, insurance, formulary, medical needs, preferred route, and budget. Use The RX Index's Find My GLP-1 Path tool to compare FDA-approved and compounded paths before you choose.

The RX Index is an independent GLP-1 decision resource that compares treatment paths on clinical legitimacy, care quality, transparency, access, and cost.

Does Fridays semaglutide work? It is really three questions

Most people asking whether Fridays semaglutide works are asking three different things at once: does approved semaglutide cause weight loss, has this exact Fridays product been tested, and can this program help them stay on a safe plan long enough to judge it. Each question has a different answer and a different kind of proof. Separating them is the fastest way to stop feeling confused.

Here's the split.

Notice something. Several of those rows are “no.” And we're still going to tell you Fridays can be a reasonable choice for the right person.

That's not a contradiction. Stay with us.

We checked the proof Fridays puts in front of shoppers

Fridays publishes three numbers a shopper could read as proof that its semaglutide works: a 96.8% success rate, 9.75 pounds lost in the first month, and 15.28% average weight reduction at 12 months. We opened the footnotes. In every case, the fine print gives the number a narrower meaning than the headline suggests.

We're not accusing Fridays of hiding the footnotes. They are on Fridays' own pages. Most people just never scroll far enough to read them.

Three proof claims. Three limits written on Fridays' own pages. Zero public, product-specific outcome evidence for the exact compounded medicine that may show up at your door.

Now — before you close this tab and swear off telehealth forever, read the next sections. “No product-specific study exists” is not the same statement as “nobody can benefit.” It means the evidence gap is real, and you should choose with your eyes open.

What is Fridays' 96.8% success rate?

Fridays' 96.8% success rate is a shipping and fulfillment number, not a weight-loss number. Fridays' own footnote defines it as recent internal fulfillment and delivery performance for paid orders during the current quarter. It tells you whether orders were fulfilled and delivered. It tells you nothing about the scale.

This one matters because it is usually the number that got you here.

You saw “96.8%” in big type. Your brain filled in the rest: 96.8% of people succeed. That's how the number lands.

Read the asterisk and it changes completely. Fridays says the figure can vary with pharmacy capacity, state rules, and order details. It also says the figure does not represent clinical outcomes or individual results.

A 96.8% fulfillment and delivery rate is genuinely fine. It's just not what you thought you were reading.

One more thing tells you how much weight to put on a headline number: Fridays' live price pages do not agree with each other. On August 28, 2026, the pricing page showed both $117 and $150 near the top, $150 per month for an annual plan farther down, and $249 for month-to-month. A separate live product page showed $279 for a one-month supply.

We're not calling that dishonest. Marketing pages get stale in a hundred small ways. But it tells you to trust the dated footnote, plan terms, and final checkout screen more than the largest number on the page.

What the semaglutide trials actually proved

Semaglutide has strong, repeated evidence for weight loss — when you look at the FDA-approved products that were actually studied. STEP 1 and STEP 5 tested the approved weekly injection. The current Wegovy label also includes an approved daily tablet with its own weight-loss study. None of these studies tested a Fridays compounded product.

Two things to take from this table.

First, look at the clock. Sixty-four weeks. Sixty-eight weeks. One hundred four weeks. The famous semaglutide numbers are not 30-day numbers or 90-day numbers. Nobody in those trials reached the final average by spring break.

Second, the exact product matters. The approved weekly injection and the approved daily tablet each have their own formulation, manufacturing controls, label, dosing schedule, and clinical data. You cannot automatically transfer those results to a compounded injection, oral liquid, sublingual product, nasal product, or microdose plan.

There is one more detail most sales pages skip. In a 140-person STEP 1 body-composition substudy, semaglutide reduced total fat mass and visceral fat, but total lean mass also fell. The lean share of total body weight improved, so this is not a simple “semaglutide eats muscle” story. It is a reason to ask your clinician or dietitian how to protect strength and lean tissue with enough protein and safe resistance work.

And the caveat that runs under all of it: these studies tested specific FDA-approved products at specific doses on specific schedules. They are excellent evidence for those products. They are not proof about a compounded Fridays preparation, and we won't pretend otherwise.

Has Fridays studied its own semaglutide?

As of August 28, 2026, we found no published clinical trial of a Fridays compounded semaglutide product. Fridays' live product page links a semaglutide whitepaper, but a paper that explains research on semaglutide is not the same thing as a trial of the product a Fridays member receives.

We searched the medical literature and the public clinical-trial registry using Fridays, Thrive Health, OpenLoop, StatRX, and compounded semaglutide terms. We found approved-product studies and general semaglutide studies. We did not find a public trial that tested a Fridays compounded formulation, a Fridays pharmacy batch, or a Fridays delivery route.

This is the one thing we'd want you to know before you pay:

Fridays has not published product-specific clinical proof for the medicine provided through its compounded program. Not one public trial we could find.

If having research on the exact product in your hand is your priority, then you should not choose compounded Fridays semaglutide. Choose an FDA-approved product. That is what the product-specific trials and FDA review cover, and you deserve to get what you're paying for.

But understand what you're trading. Fridays does not offer product-specific trial proof. Its program offers a cash-pay access path, third-party clinician review, pharmacy coordination, and a broad support bundle. Fridays advertises unlimited provider visits, dietitian access, group coaching, fitness support, and medication included in compounded plans.

That's a real trade. Plenty of sensible people make it on purpose. Just make it on purpose — and ask the clinician to explain why a compounded version is medically appropriate for you now that the national semaglutide shortage has been resolved.

→ If FDA-approved is your non-negotiable: Ro offers FDA-approved GLP-1 paths and a free coverage checker for the Ozempic pen, Wegovy pen, and Zepbound pen. Check your insurance coverage on Ro (affiliate link).

How much weight do people lose on semaglutide in real life?

Real-world semaglutide results were lower than the headline STEP 1 average. In a Cleveland Clinic study, 6,109 people who started injectable semaglutide lost an average of 7.7% at one year. People without a treatment gap longer than 90 days averaged 10.9%. Those without a long gap who also reached a high maintenance dose averaged 13.7%.

This is the section that should change what you do next.

The study followed 7,881 adults in Ohio and Florida who started injectable semaglutide or tirzepatide between 2021 and 2023. Of those, 6,109 started semaglutide. It was a review of real medical and prescription records, not a randomized trial.

The study used a strict definition: “discontinuation” meant a gap longer than 90 days after the prior supply ran out. A late package or one missed weekly dose is not the same thing as the study's discontinuation group.

That correction matters. We are not going to turn an observational study into a scare line about one late refill.

The study also does not prove that staying on treatment or reaching a higher dose caused every extra pound of loss. People who continue treatment can differ from people who stop in many ways. Still, the pattern is hard to ignore: long gaps and low maintenance doses traveled with weaker average results.

So here's the sentence we want you to keep:

Fridays cannot promise the 14.9% trial result, and the 11.9% number you may see elsewhere is not a semaglutide-only number. The semaglutide-only real-world averages were 7.7% overall, 10.9% without a long gap, and 13.7% without a long gap at a high maintenance dose.

Your job is not to chase the highest number. Your job is to know which evidence applies to your product, follow the plan your clinician gives you, report side effects early, avoid self-adjusting the dose, and keep the billing and shipment system from surprising you.

How do Fridays semaglutide refills work now?

Fridays changed its compounded-medication refill system on August 27, 2026. New compounded GLP-1 patients now receive a 12-week prescription after one approved request, with three shipments sent about four weeks apart. Existing compounded patients move to the new system at their next refill. Billing stays separate from the prescription.

This replaces the old “request a refill after your third weekly dose” rule for compounded semaglutide.

If you take one action from this section, make it this: the day your first shipment arrives, save four things — your next shipment window, week-12 request window, next billing date, and cancel-by date.

That takes less than a minute. It helps prevent avoidable billing and shipment surprises.

→ If the care bundle is the reason Fridays fits you: Fridays advertises unlimited provider visits, dietitian support, group coaching, fitness support, and medication included in compounded plans. Because its public prices conflict, check the full amount due before you pay. Check eligibility and see what Fridays currently offers (affiliate link).

How long does Fridays semaglutide take to work?

Judge semaglutide over months, not days. Weekly injectable semaglutide has a half-life of about one week, so repeated doses build in the body over several weeks. Approved Wegovy injection also starts low and steps up over time. Your compounded schedule may differ, so your own label and clinician's instructions control.

Here is a realistic way to think about the clock.

Things that are not a clean medication verdict: one flat week, one heavier morning after a salty meal, a menstrual-cycle change, or a brief plateau.

Things worth sending to your provider: no meaningful appetite or weight change after the clinician says you have reached an appropriate maintenance plan, side effects that stop you from eating or drinking normally, repeated vomiting, new severe pain, or any confusion about the label, concentration, route, or dose.

Nothing's happening. Is my Fridays semaglutide not working?

Before assuming the medication is the problem, check the exact product, route, dose, concentration, treatment time, missed doses, long gaps, and storage instructions. The first few weeks are too early to compare yourself with results measured at 64, 68, or 104 weeks. If your clinician says you have reached an appropriate maintenance plan and there is still no meaningful change, ask for a full reassessment.

We know why you're reading this section, and we're not going to pad it. Run this list.

1. What exact product did you receive? Read the pharmacy name, ingredient name, route, concentration, beyond-use date, and storage directions on the label. Do not rely on a website photo. Fridays says it does not manufacture the medication and that the product you receive may look different from website images.

2. What dose are you actually taking? Write it in milligrams, not only “units.” A syringe may show units while the prescription is written in milligrams. The concentration of the vial decides how those numbers connect.

3. Have you had missed doses or a long break? Tell the provider the exact dates. Do not guess how to restart. Fridays' help center says dose changes may be needed after a break, and the right restart depends on your own situation.

4. Has it actually been long enough? The big approved-product results were measured after 64, 68, or 104 weeks. Your clinician may decide sooner that a product, dose, or route is not right for you, but week three is not the same endpoint as week 68.

5. Is something else in play? New medicines, thyroid disease, sleep loss, severe stress, constipation, fluid shifts, or another health change can affect what you feel and what the scale shows. Tell the clinician the whole story.

6. Did the shipment arrive as expected? FDA recommends that patients do not use an injectable GLP-1 drug that arrives warm or with inadequate refrigeration when cold storage is required. Follow the storage directions for your exact product and contact the pharmacy before using it if the package condition does not match those directions.

One thing to never do: do not increase your own dose to force a result. FDA has received reports of serious harm and hospital care after people injected 5 to 20 times the intended amount from compounded multi-dose vials. Confusion between milligrams, milliliters, concentration, and syringe units is the problem.

If you are unsure how to measure the dose, ask before you inject. Every time.

Here is what to send your provider. Copy it:

“I started on [date]. My label says [exact ingredient and concentration]. My current prescribed dose is [mg], which the instructions say is [units or mL]. I have had [number and dates] of missed or delayed doses. I have noticed [appetite change, weight change, side effects, or none]. What should I expect at this stage, and do you want to review my product, route, dose, or schedule?”

Get urgent medical help for symptoms such as persistent or severe abdominal pain, repeated vomiting with trouble keeping fluids down, fainting, trouble breathing, or swelling of the face, lips, tongue, or throat. Fridays' service is not an emergency service.

And a word about reviews. Some Fridays customers report major weight loss. Other people report little change. Both can be real. Neither review tells you the exact product, dose, route, treatment gap, health history, or other factors that explain the result.

Do Fridays' pill, nasal, sublingual, or microdose versions work like the shot?

Do not assume that every product called semaglutide works like every other semaglutide product. FDA-approved Wegovy now comes as both a weekly injection and a daily tablet, and each approved form has product-specific evidence. A compounded oral, nasal, sublingual, or microdose product is a different formulation and cannot borrow the approved product's proof.

The live Fridays semaglutide product page currently makes the route question more important, not less. It displays the labels “Daily Oral” and “Daily Nasal” above a product it then describes as a one-month supply of once-weekly injections. That may be a page-template problem. It is still a reason to confirm the exact route before checkout and again on the pharmacy label.

Now the practical truth: a format you can follow matters. But adherence cannot erase a formulation evidence gap.

If needles genuinely stop you, an FDA-approved tablet may now be one path to discuss. If you choose a compounded non-injection format, ask the provider what published evidence supports that exact route, dose, and formulation.

FDA has also received adverse-event reports tied to compounded semaglutide or tirzepatide prescribed at doses or escalation schedules beyond the approved labels — more per dose, more often, or increasing faster. Ask what schedule you are on and why. Do not copy an online dose chart onto a compounded vial with a different concentration.

Is Fridays semaglutide FDA approved?

No. Fridays' compounded semaglutide is not FDA-approved, and FDA does not review compounded drugs for safety, effectiveness, or quality before they are sold. Fridays states this on its own pages.

Let's be precise, because this term gets thrown around loosely.

“Not FDA-approved” does not automatically mean fake or counterfeit. It also does not mean every compounded copy is automatically lawful. Patient-specific compounding can be lawful when federal and state conditions are met. The prescription, pharmacy type, formulation, route, and documented patient need matter.

The national semaglutide injection shortage was declared resolved in February 2025, and the shortage-related enforcement windows ended in 2025. In April 2026, FDA again reminded compounders that semaglutide and tirzepatide were not on the shortage list or the 503B bulks list.

For a state-licensed 503A pharmacy, FDA says an essentially identical copy of a commercially available drug generally falls outside the exception unless a prescriber identifies and documents a change that makes a significant difference for a named patient. Adding B12 or changing the dose does not automatically settle that question.

That means “I want the cheaper copy” is not the same thing as a documented patient-specific clinical difference. Ask the clinician this exact question:

“What patient-specific medical need makes this compounded formulation appropriate for me, and what difference are you documenting?”

Fridays' terms name four partner pharmacies: RedRock Pharmacy, Health Warehouse, Precision Medicine, and Triad Rx. Fridays also says it is not the pharmacy and does not manufacture the medication. The label on the product you receive is what tells you which pharmacy filled your prescription.

FDA has published specific compounded-GLP-1 concerns worth knowing:

• Salt forms: FDA says semaglutide sodium and semaglutide acetate are different active ingredients from the one used in approved drugs. FDA says it lacks information showing the same chemical and pharmacologic properties and is not aware of a lawful basis for using those salt forms in compounding.
• Shipping temperature: FDA recommends not using an injectable GLP-1 product that arrives warm or with inadequate refrigeration when cold storage is required.
• Dosing errors: FDA has received reports of patients and clinicians miscalculating doses from multi-dose vials, including 5-to-20-times overdoses and hospitalizations.
• Faster or higher-than-label schedules: FDA has received adverse-event reports tied to compounded products prescribed at larger doses, more often, or with faster titration than the approved labels.
• Fraudulent labels: FDA has found products labeled with pharmacies that did not exist or did not make the product.
• Adverse-event reports: As of May 31, 2026, FDA had received 990 reports associated with compounded semaglutide and more than 730 associated with compounded tirzepatide. Those counts are not event rates and do not prove the drug caused every report. FDA also says state-licensed pharmacies generally are not required to report, so the totals are incomplete.

Fridays says its compounded medications are produced in FDA-registered facilities. That statement does not change the product's status. Fridays says in the same disclosure that the compounded medication is not FDA-approved and has not been evaluated by FDA for safety, efficacy, or quality.

Five questions to ask before your first dose. Screenshot these:

1. Which pharmacy is filling my prescription?
2. What exact ingredient name is on the prescription and label — semaglutide base, semaglutide sodium, semaglutide acetate, or something else?
3. Is anything else in the formulation, such as B12, and why is it there?
4. What is the concentration, what is my dose in milligrams, and exactly how many milliliters or syringe units is that?
5. How should this exact product be stored, and what should I do if it arrives warm, damaged, late, or different from what I expected?

What does Fridays semaglutide cost?

There is no single public Fridays semaglutide price we can safely promise you today. The clearest current help-center schedule lists $249 month to month, $596 for three months, $1,050 for six months, and $1,800 for 12 months. But Fridays' live sales pages also show $117, $150, and $279. Confirm the full charge at checkout before paying.

Keeping this concrete, because the conflict is the finding.

Provider-stated price audit — verified August 28, 2026

Four things to screenshot at checkout: amount charged today, how many months it covers, next billing date, and next billing amount.

If the page does not show all four clearly, ask support to confirm them in writing before you pay.

Also save these terms:

• Your subscription renews automatically at the interval shown when you enroll.
• Fridays requires cancellation at least 72 hours before the next billing date to avoid the next renewal.
• Fridays does not offer a standard pause. You can cancel and later reactivate.
• Multi-month plans are paid upfront.
• Fees are generally not refundable because you stopped, changed your mind, or did not get the result you wanted.
• A damaged or incorrect shipment should be reported within 24 hours; Fridays' stated standard remedy is replacement, not a refund.

A note in Fridays' favor: its pricing page says compounded plans include medication, provider visits, dietitian support, group coaching, and other program services, with no separate membership, sign-up, or lab fee listed. The support bundle is a real part of what you are paying for.

For the narrower billing questions, see Does Fridays have a membership fee?, Does Fridays take insurance?, and Does Fridays take FSA or HSA?.

Who should choose Fridays — and who should walk away?

Fridays can fit a cash-paying adult who understands the evidence gap, has a patient-specific reason for compounding that the prescriber can explain, wants a broad support bundle, and can afford the full plan. It is a poor fit for someone who wants the exact FDA-approved product, may have brand coverage, wants a guaranteed refund, or cannot confirm the final price and prescription details before paying.

Find yourself here.

The “try it for a month” row is the one we'd underline. One month is too short to compare yourself with outcomes measured at 64, 68, or 104 weeks, and Fridays does not promise a result-based refund.

Waiting is a legitimate choice. Checking insurance first is a legitimate choice. Choosing the approved product is a legitimate choice. Choosing a compounded path after a clinician explains the patient-specific reason is also a choice an informed adult may make.

The point is not to push you across one line. The point is to make sure you can see the line.

What real customers say — and what reviews cannot tell you

Customer reviews are useful for judging support, shipping, app access, and billing. They are weak evidence for whether semaglutide works, because reviewers rarely show the exact product, route, concentration, dose, timeline, long gaps, or health history. As of August 28, 2026, Fridays had a 4.2 Trustpilot score across 4,644 reviews.

The distribution matters more than the rounded star:

First, something you should know before you weigh any Fridays testimonial: Fridays' own weight-loss page says the featured members were paid for their testimonials. Fridays also links a public creator-affiliate program from its product page.

That does not make those people liars. It does make the videos advertisements, and you should weigh them that way.

The live Fridays pricing page also says “4.5 stars | 4K+ reviews” near the top and “Excellent 2,000+ reviews” farther down. We used the live Trustpilot page instead: 4.2 across 4,644 reviews on the date we checked.

Do individual people report major weight loss through Fridays? Yes. Does that prove the compounded product will work for you? No. Fridays has not published a semaglutide-only outcome cohort with a sample size, dose breakdown, route breakdown, comparator, and follow-up method that lets us calculate a trustworthy expected result.

Hold both facts at once: many customers may be happy, and the product-specific clinical evidence gap still exists.

How we checked all of this

We are not Fridays patients. We did not enroll, place an order, receive a prescription, test a vial, or measure any batch's potency. Everything on this page comes from documents you can open yourself: Fridays' live product, pricing, terms, weight-loss, and help-center pages; FDA alerts and compounding updates; the current Wegovy label; peer-reviewed trials; a real-world medical-record study; and public Trustpilot data.

What we verified — August 28, 2026

• Read the live Fridays pricing page and recorded every semaglutide price displayed
• Read the current compounded-plan pricing help-center article
• Read the August 27, 2026 refill-system update and separated the compounded 12-week process from brand-name monthly refills
• Read Fridays' current terms for partner pharmacies, billing, cancellation, refunds, and damaged shipments
• Pulled the 96.8% footnote directly from Fridays' live page
• Pulled the 9.75-pound and 15.28% figures and their mixed-medication disclaimer from Fridays' live weight-loss page
• Confirmed Fridays' “not FDA-approved / not evaluated by FDA” disclosure
• Checked FDA's current compounded-GLP-1 concerns, salt-form warning, dosing-error alert, adverse-event counts, and post-shortage compounding policy
• Checked the current Wegovy label for the injection, approved tablet, contraindications, pregnancy timing, dosing, and clinical-study results
• Traced the 7.7%, 10.9%, and 13.7% semaglutide figures to the full Cleveland Clinic study
• Checked the live Trustpilot score, review count, and rating distribution
• Searched public literature and trial registries for a Fridays, Thrive, OpenLoop, StatRX, or Fridays-product semaglutide trial

What we could not verify

• We did not test the medication or verify any batch's identity, sterility, potency, purity, or stability
• We did not independently confirm the current state-license status or inspection history of every pharmacy named in Fridays' terms
• We found no published clinical trial of a Fridays compounded semaglutide product
• Fridays does not publish enough detail on the 9.75-pound or 15.28% internal cohorts for us to reproduce or independently validate those numbers
• We cannot tell you whether your exact prescription meets every federal and state compounding condition; that depends on the patient-specific facts, prescriber documentation, pharmacy, formulation, and applicable law
• We cannot tell you whether you personally will respond. Nobody can

Where Fridays lands on our five pillars

Use this 12-week Fridays control card

The old monthly refill reminder is no longer the right tool for a new compounded semaglutide patient. Use this instead.

Day 1: save the facts

• Pharmacy name
• Exact ingredient and route
• Concentration
• Prescribed dose in milligrams
• Matching volume or syringe units
• Storage range
• Beyond-use date
• Amount charged today
• Next billing date
• Cancel-by date, at least 72 hours earlier

Around weeks 4 and 8: watch the automatic shipments

• Check your email and patient portal for tracking
• Confirm the next package is from the pharmacy you expected
• Inspect it as soon as it arrives
• Report a damaged or incorrect shipment within 24 hours
• Contact the pharmacy before using it if temperature or packaging does not match the label's storage rules

Before week 12 ends: protect the next prescription

• Watch for Fridays' notice that a new medication request or video consultation is due
• Leave room for the stated 2–3-day provider review and 5–7-business-day delivery window
• Do not guess how to bridge a gap or restart after one
• Confirm whether your next 12 weeks will use the same product, route, concentration, and pharmacy

Before every injection

• Match the label to the prescription
• Confirm milligrams, concentration, volume, and syringe units
• Never use an old syringe conversion for a new concentration
• Never increase the dose on your own

This card does not calculate doses, and it never should. That is your clinician's and pharmacist's job. FDA's dosing-error reports are exactly why.

Frequently asked questions

Is Fridays semaglutide FDA approved?

No. Fridays' compounded semaglutide is not FDA-approved. FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Fridays states this on its own pages.

Is Fridays semaglutide the same as Wegovy or Ozempic?

No. Wegovy injection and Wegovy tablets are FDA-approved finished drugs with approved labels and product-specific evidence. Ozempic is FDA-approved for type 2 diabetes, not for weight loss. A Fridays compounded product is prepared by a compounding pharmacy and is not reviewed by FDA as an equivalent finished drug.

Does Fridays' 96.8% success rate mean 96.8% of people lose weight?

No. Fridays' own footnote says the number measures recent internal fulfillment and delivery performance for paid orders. It does not represent clinical outcomes or individual results.

What is Fridays' average weight loss?

Fridays reports 9.75 pounds in the first month for one internal group and 15.28% average body-weight reduction at 12 months for another. Fridays says those results span a range of prescribed medications and are not tied to one formulation, brand, or specific medicine. They are not semaglutide-only figures.

How much weight do people lose on semaglutide in real life?

In the Cleveland Clinic study, 6,109 semaglutide patients averaged 7.7% at one year. Those without a treatment gap longer than 90 days averaged 10.9%. Those without a long gap who reached a high maintenance dose averaged 13.7%. The study was observational and did not test Fridays.

How long does Fridays semaglutide take to work?

Some people feel appetite changes early, but the strongest weight-loss evidence is measured over many months. Approved-product studies reported final averages at 64, 68, or 104 weeks. Your clinician should judge your response based on the exact product, route, dose, side effects, and time — not one early weigh-in.

How do Fridays compounded-semaglutide refills work now?

For new compounded patients starting on or after August 27, 2026, one approved request covers a 12-week prescription and three shipments sent about four weeks apart. Existing compounded patients move to this process at their next refill. At the end of 12 weeks, a new request or consultation is needed. Billing remains separate.

Why is compounded semaglutide cheaper than FDA-approved brands?

It is a different product and business model. The compounded product does not carry the same product-specific FDA approval, manufacturing, labeling, and evidence package as Wegovy. A lower price does not make the two products equivalent.

What happens if I stop taking semaglutide?

Weight regain is common. In the STEP 1 extension, participants regained about two-thirds of the weight they had lost during the year after semaglutide and lifestyle treatment stopped. Plan any stop or switch with your clinician.

Is compounded semaglutide safe?

No article can declare an unknown batch safe for you. FDA does not review compounded drugs before marketing and has warned about dosing errors, warm shipments, fraudulent labels, salt forms, and higher or faster-than-label schedules. Discuss the exact prescription and product with the prescriber and dispensing pharmacy.

Can I get a refund if I do not lose weight?

Fridays' terms say fees are generally non-refundable when a customer does not achieve the desired result. Listed exceptions include medical disqualification before services begin, verified billing errors, refunds required by law, and some program-switch credits.

Which pharmacy fills my Fridays prescription?

Fridays' terms name RedRock Pharmacy, Health Warehouse, Precision Medicine, and Triad Rx as partner pharmacies. The label on the medication you receive tells you which pharmacy filled your prescription. Ask before using it if the label, product, or pharmacy is not what you expected.

Still not sure which GLP-1 program is right for you?

We built Find My GLP-1 Path for exactly this moment — when you understand the tradeoffs but still cannot tell which side of them you are on.

Answer a few questions about your state, insurance, whether you want FDA-approved or compounded, your preferred route, and your budget. You will get a path built around those answers instead of one provider being forced onto everyone.

Get my personalized GLP-1 path →

The RX Index is an independent GLP-1 decision resource that compares telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost.

Related reading: Does Fridays have a membership fee? · Does Fridays take insurance? · Does Fridays take FSA or HSA? · How to get insurance to cover a GLP-1

Sources

• FDA: Concerns with unapproved GLP-1 drugs used for weight loss
• FDA: Policies for compounders after national GLP-1 supply stabilized
• FDA: Dosing errors with compounded injectable semaglutide
• DailyMed: Current Wegovy injection and tablet label
• Fridays pricing page
• Fridays compounded semaglutide product page
• Fridays semaglutide whitepaper
• Fridays weight-loss page and outcome disclaimers
• Fridays program terms and conditions
• Fridays help center: Current compounded-plan pricing
• Fridays help center: Current refill and billing process
• Fridays help center: Pause and cancellation policy
• Wilding et al.: STEP 1
• Garvey et al.: STEP 5
• Lincoff et al.: SELECT
• Gasoyan et al.: Real-world semaglutide and tirzepatide outcomes by discontinuation and dose
• Wilding et al.: STEP 1 body-composition substudy
• Wilding et al.: STEP 1 withdrawal extension
• Trustpilot: Fridays Health reviews

This page is for information only and is not medical advice. Talk to a licensed clinician and the dispensing pharmacist about your own prescription before starting, stopping, switching, or changing any treatment. Call 911 or seek urgent care for a medical emergency.